Skip to main content
. 2019 Jan 15;11(1):442–452.

Figure 1.

Figure 1

CCL7 expression is negatively correlated with the clinical outcome of non-small cell lung cancer (NSCLC) patients. A. Immunohistochemical detection of CCL7 expression in NSCLC bone metastasis, primary NSCLC and normal lung tissues (n = 40). B. Statistics of all samples associated with CCL7 staining. C. qRT-PCR assay of mRNA level of CCL7 in NSCLC bone metastasis, primary NSCLC and normal lung tissues. D. qRT-PCR assay of mRNA level of CCL7 in various lung cancer cell lines. E, F. High CCL7 mRNA expression is positively correlated with poor overall survival (OS) and progression-free survival (FPS) in NSCLC patients. *: P < 0.05.